Filtros de búsqueda

Lista de obras de A Rivero

A 24-week treatment strategy with pegylated interferon/ribavirin in HIV/hepatitis C virus genotype 3-coinfected patients who achieved a rapid virologic response results in a high sustained virologic response rate.

artículo científico publicado en 2013

A case-control study of HIV patients with the K65R mutation in the reverse transcriptase gene with virological failure

artículo científico publicado en 2005

A polymorphism linked to RRAS, SCAF1, IRF3 and BCL2L12 genes is associated with cirrhosis in hepatitis C virus carriers.

artículo científico publicado en 2013

Absence of occult Hepatitis E virus infection among HIV immunosuppressed patients

artículo científico publicado en 2014

Age-dependent association between low frequency of CD27/CD28 expression on pp65 CD8+ T cells and cytomegalovirus replication after transplantation.

artículo científico publicado en 2009

Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C

artículo científico publicado en 2006

Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients

artículo científico publicado en 2008

Association of complement receptor 2 polymorphisms with innate resistance to HIV-1 infection

artículo científico publicado en 2015

Association of low-density lipoprotein receptor genotypes with hepatitis C viral load

artículo científico publicado en 2013

Atazanavir-based therapy with pegylated interferon and ribavirin for patients with hepatitis C and HIV.

artículo científico publicado en 2014

Bacterial translocation and clinical progression of HCV-related cirrhosis in HIV-infected patients

artículo científico publicado en 2017

Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patients.

artículo científico publicado en 2008

Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy

artículo científico publicado en 2015

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial ⬇️

artículo científico publicado el 12 de junio de 2013

Burden of HIV infection, vulnerable populations and access barriers to healthcare

scientific article published on 01 September 2018

CD8(+)HLA-G(+) regulatory T cells are expanded in HIV-1-infected patients.

artículo científico publicado en 2009

Cardiac tamponade caused by Nocardia asteroides in an HIV-infected patient

scientific article published on 01 March 2000

Changes in liver steatosis evaluated by transient elastography with the controlled attenuation parameter in HIV-infected patients

artículo científico publicado en 2016

Clinical differences between invasive pulmonary infection by Scedosporium apiospermum and invasive pulmonary aspergillosis ⬇️

artículo científico publicado el 14 de junio de 2011

Clinical epidemiology of Stenotrophomonas maltophilia colonization and infection: a multicenter study.

artículo científico publicado en 2002

Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy.

artículo científico publicado en 2007

Common haplotypes in CD209 promoter and susceptibility to HIV-1 infection in intravenous drug users.

artículo científico publicado en 2016

Community-acquired bacterial pneumonia in human immunodeficiency virus-infected patients: validation of severity criteria. The Grupo Andaluz para el Estudio de las Enfermedades Infecciosas.

artículo científico publicado en 2000

Control of Epstein-Barr virus load and lymphoproliferative disease by maintenance of CD8+ T lymphocytes in the T lymphocyte-depleted graft after bone marrow transplantation.

artículo científico publicado en 2004

Costs and cost-efficacy analysis of the 2014 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.

artículo científico publicado en 2014

Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults

artículo científico publicado en 2016

Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.

artículo científico publicado en 2017

Current views on interferon therapy for HIV.

artículo científico publicado en 2016

Darunavir in HIV/HVC/HVB coinfection

artículo científico publicado en 2008

Detection of hepatitis E virus RNA in saliva for diagnosis of acute infection

artículo científico publicado en 2018

Differences in HCV viral decline between low and standard-dose pegylated-interferon-alpha-2a with ribavirin in HIV/HCV genotype 3 patients

artículo científico publicado en 2012

Differences in virological response to peginterferon-α plus ribavirin in HIV-positive patients coinfected with HCV subtypes 1a or 1b.

artículo científico publicado en 2012

Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype.

artículo científico publicado en 2011

Differential timing of cholesterol increase during successful HCV therapy: impact of type of drug combination.

artículo científico publicado en 2018

Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain

artículo científico publicado en 2015

Does lopinavir/ritonavir alter the primary gingival epithelium? ⬇️

artículo científico publicado el 1 de diciembre de 2010

Dual therapy with darunavir and ritonavir plus lamivudine versus triple therapy with darunavir and ritonavir plus tenofovir disoproxil fumarate and emtricitabine or abacavir and lamivudine for maintenance of HIV-1 viral suppression: randomised, open

artículo científico publicado en 2017

Effectiveness and safety of simplification from tenofovir-lamivudine (TDF-3TC) to tenofovir-emtricitabine (TDF-FTC) co-formulation (Truvada) in virologically suppressed HIV-infected patients on HAART.

artículo científico publicado en 2008

Effects of the genetic pattern defined by low-density lipoprotein receptor and IL28B genotypes on the outcome of hepatitis C virus infection.

artículo científico publicado en 2013

Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study

artículo científico publicado en 2017

Efficacy and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretrovirals

artículo científico publicado en 2010

Efficacy and safety of pegylated interferon plus ribavirin in HIV and hepatitis C virus-coinfected patients with advanced immunosuppression.

artículo científico publicado en 2009

Efficacy of Low-Dose Boosted Saquinavir Once Daily Plus Nucleoside Reverse Transcriptase Inhibitors in Pregnant HIV-1-Infected Women With a Therapeutic Drug Monitoring Strategy

article

Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis

artículo científico publicado en 2018

Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia.

artículo científico publicado en 2015

Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimen.

artículo científico publicado en 2008

Efficacy, safety and pharmacokinetic of once-daily boosted saquinavir (1500/100 mg) together with 2 nucleos(t)ide reverse transcriptase inhibitors in real life: a multicentre prospective study.

artículo científico publicado en 2010

Etiology of spontaneous pneumothorax in 105 HIV-infected patients without highly active antiretroviral therapy

article

Evaluation of a non-invasive screening approach to determine hepatitis E virus status of pig farms

artículo científico publicado en 2020

Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014).

artículo científico

Executive summary of the consensus document on the management of renal disease in HIV-infected patients.

artículo científico publicado en 2014

Executive summary of the recommendations on the evaluation and management of renal disease in human immunodeficiency virus-infected patients

artículo científico publicado en 2014

Executive summary: Consensus document of the diagnosis, management and prevention of infection with the hepatitis E virus: Study Group for Viral Hepatitis (GEHEP) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)

article

Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

artículo científico publicado en 2016

Factors related to the development of CMV-specific CD8+ T cell response in CMV-seropositive solid organ transplant candidates.

artículo científico publicado en 2015

Familial Hepatitis E Outbreak Linked to Wild Boar Meat Consumption

artículo científico publicado en 2017

Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus.

artículo científico publicado en 2009

Fat mass and obesity-associated gene variations are related to fatty liver disease in HIV-infected patients.

artículo científico publicado en 2017

Fever of intermediate duration

artículo científico publicado en 2003

GESIDA/GESITRA-SEIMC, PNS and ONT consensus document on solid organ transplant (SOT) in HIV-infected patients in Spain (March, 2005)

artículo científico publicado en 2005

HAART induces the expression of HLA-G on peripheral monocytes in HIV-1 infected individuals.

artículo científico publicado en 2003

HCV viral decline at week 2 of Peg-IFN-alpha-2a/RBV therapy as a predictive tool for tailoring treatment in HIV/HCV genotype 1 co-infected patients.

artículo científico publicado en 2014

HIV pre-exposure prophylaxis (PrEP) in Spain: political and administrative situation

artículo científico publicado en 2018

HIV/hepatitis C virus-coinfected patients who achieved sustained virological response are still at risk of developing hepatocellular carcinoma.

artículo científico publicado en 2014

HLA-B, HLA-C and KIR improve the predictive value of IFNL3 for Hepatitis C spontaneous clearance.

artículo científico publicado en 2018

HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: implications for timing of therapy.

artículo científico publicado en 2016

HLA-B18 as risk factor of liver fibrosis progression in HIV/HCV treatment-experienced patients.

artículo científico publicado en 2016

Hepatic safety of maraviroc in HIV-1-infected patients with hepatitis C and/or B co-infection. The Maraviroc Cohort Spanish Group.

artículo científico publicado en 2016

Hepatic safety of tipranavir plus ritonavir (TPV/r)-based antiretroviral combinations: effect of hepatitis virus co-infection and pre-existing fibrosis.

artículo científico publicado en 2008

Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients.

artículo científico publicado en 2012

Hepatitis C virus core antigen in the management of patients treated with new direct-acting antivirals

artículo científico publicado en 2017

Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients.

artículo científico publicado en 2012

Hepatitis E Virus (HEV) Infection in Anti-HEV Immunoglobulin G-Carrying Patients After Successful Hepatitis C Virus Treatment: Reactivation or Reinfection?

artículo científico publicado en 2017

Hepatitis E virus in Spanish donors and the necessity for screening

artículo científico publicado en 2019

Hepatitis E virus infection in equines in Spain

article

High hepatitis E virus seroprevalence with absence of chronic infection in HIV-infected patients

artículo científico publicado en 2014

High prevalence of antibodies against hepatitis E virus in HIV-infected patients with unexplained liver disease

artículo científico publicado en 2014

High rate of tuberculosis reinfection during a nosocomial outbreak of multidrug-resistant tuberculosis caused by Mycobacterium bovis strain B

artículo científico publicado en 2000

Human Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining Conditions

artículo científico publicado en 2016

Human Immunodeficiency Virus/Hepatitis C Virus Coinfection in Spain: Prevalence and Patient Characteristics.

artículo científico publicado en 2016

IFNL4 rs368234815 polymorphism is associated with innate resistance to HIV-1 infection.

artículo científico publicado en 2015

IFNL4 ss469415590 variant shows similar performance to rs12979860 as predictor of response to treatment against Hepatitis C Virus genotype 1 or 4 in Caucasians

artículo científico publicado en 2014

Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin

artículo científico publicado en 2015

Impact of age and cytomegalovirus on CD8+ T-cell compartment remodeling after solid organ transplantation: A one-year follow-up study

artículo científico publicado en 2017

Impact of genetic polymorphisms associated with nonalcoholic fatty liver disease on HIV-infected individuals

artículo científico publicado en 2015

Impact of the PROVAUR stewardship programme on linezolid resistance in a tertiary university hospital: a before-and-after interventional study.

artículo científico publicado en 2016

Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy

artículo científico publicado en 2016

Impaired response of HIV type 1-specific CD8(+) cells from antiretroviral-treated patients

artículo científico publicado en 2007

Incidence and natural history of hepatitis E virus coinfection among HIV-infected patients

artículo científico publicado en 2014

Incidence of liver damage of uncertain origin in HIV patients not co-infected with HCV/HBV.

artículo científico publicado en 2013

Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain

artículo científico publicado en 2012

Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients.

artículo científico publicado en 2007

Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.

artículo científico publicado en 2011

Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients

article

Interobserver concordance in the assessment of liver fibrosis in HIV/HCV-coinfected patients using transient elastometry.

artículo científico publicado en 2010

Introduction. Usefulness of atazanavir in the treatment of patients infected by human immunodeficiency virus

artículo científico publicado en 2008

Is it time to start new HIV prevention strategies in Spain?

artículo científico publicado en 2017

Isolation of Hepatitis E Virus From Breast Milk During Acute Infection

artículo científico publicado en 2016

KIR2DS2 as predictor of thrombocytopenia secondary to pegylated interferon-alpha therapy

artículo científico publicado en 2016

LDLr genotype modifies the impact of IL28B on HCV viral kinetics after the first weeks of treatment with PEG-IFN/RBV in HIV/HCV patients.

artículo científico publicado en 2012

Lack of short-term increase in serum mediators of fibrogenesis and in non-invasive markers of liver fibrosis in HIV/hepatitis C virus-coinfected patients starting maraviroc-based antiretroviral therapy.

artículo científico publicado en 2012

Lipid Changes in Virologically Suppressed HIV-Infected Patients Switching from any Antiretroviral Therapy to the Emtricitabine/Rilpivirine/Tenofovir Single Tablet: GeSida Study 8114.

artículo científico publicado en 2016

Lipid changes in HIV-patients switching to the coformulated single tablet FTC/RPV/TDF (Eviplera®). Efficacy and safety analysis. GeSida Study 8114

artículo científico publicado en 2014

Liver Toxicity of Current Antiretroviral Regimens in HIV-Infected Patients with Chronic Viral Hepatitis in a Real-Life Setting: The HEPAVIR SEG-HEP Cohort

artículo científico publicado en 2016

Liver fibrosis, host genetic and hepatitis C virus related parameters as predictive factors of response to therapy against hepatitis C virus in HIV/HCV coinfected patients

artículo científico publicado en 2014

Liver stiffness as a predictor of esophageal varices requiring therapy in HIV/hepatitis C virus-coinfected patients with cirrhosis.

artículo científico publicado en 2009

Liver stiffness correlates with Child-Pugh-Turcotte and MELD scores in HIV/hepatitis C virus-coinfected patients with cirrhosis.

artículo científico publicado en 2012

Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosis

artículo científico publicado en 2016

Liver stiffness using transient elastography is applicable to canines for hepatic disease models.

artículo científico publicado en 2012

Liver tolerance of raltegravir-containing antiretroviral therapy in HIV-infected patients with chronic hepatitis C

article

Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors.

artículo científico publicado en 2007

Liver toxicity of antiretroviral combinations including fosamprenavir plus ritonavir 1400/100 mg once daily in HIV/hepatitis C virus-coinfected patients.

artículo científico publicado en 2011

Long-term assessment of didanosine, lamivudine, and efavirenz in antiretroviral-naive patients: 3-year follow-up.

artículo científico publicado en 2008

Longitudinal evaluation of hepatitis C viral persistence in HIV-infected patients with spontaneous hepatitis C clearance

artículo científico publicado en 2015

Low incidence of severe liver events in HIV patients with and without hepatitis C or B coinfection receiving lopinavir/ritonavir

scientific article published on 01 November 2006

Low incidence of severe liver toxicity in patients receiving antiretroviral combinations including atazanavir

artículo científico publicado en 2006

Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir.

artículo científico publicado en 2008

Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term.

artículo científico publicado en 2015

Low-density lipoprotein receptor genotyping enhances the predictive value of IL28B genotype in HIV/hepatitis C virus-coinfected patients.

artículo científico publicado en 2011

Lumbar tumor in a patient with AIDS

artículo científico publicado en 2002

Management of chronic hepatitis C infection in patients infected with the human immunodeficiency virus: from what we know to what we ignore

artículo científico publicado en 2001

Minor emtricitabine intolerance in treatment-stable patients switched from tenofovir/lamivudine to a fixed-dose combination of tenofovir/emtricitabine (Truvada).

artículo científico publicado en 2007

Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV.

artículo científico publicado en 2010

Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients.

artículo científico publicado en 2009

Nucleoside reverse transcriptase inhibitors are able and protease inhibitors unable to induce the tolerogenic molecule HLA-G1 on monocytes from HIV-1 infected patients

artículo científico publicado en 2006

Paritaprevir/ritonavir/ombitasvir plus dasabuvir in HIV/HCV-coinfected patients with genotype 1 in real-life practice

artículo científico publicado en 2018

Patterns of lymphotropic herpesvirus viraemia in HIV-infected patients with Kaposi's sarcoma treated with highly active antiretroviral therapy and liposomal daunorubicin.

artículo científico publicado en 2000

Pegylated interferon plus ribavirin is suboptimal in IL28B CC carriers without rapid response.

artículo científico publicado en 2013

Persistence of hepatitis E virus in the liver of non-viremic naturally infected wild boar.

artículo científico publicado en 2017

Persistence of pathological distribution of NK cells in HIV-infected patients with prolonged use of HAART and a sustained immune response

artículo científico publicado en 2015

Pharmacodynamic and pharmacokinetic evaluation of the combination of daclatasvir/sofosbuvir/ribavirin in the treatment of chronic hepatitis C

artículo científico publicado en 2018

Pharmacogenetics and the treatment of HIV-/HCV-coinfected patients

artículo científico publicado en 2018

Pharmacokinetic and pharmacodynamic evaluation of telaprevir for the treatment of hepatitis C.

artículo científico

Pharmacokinetic drug evaluation of velpatasvir plus sofosbuvir for the treatment of hepatitis C virus infection.

artículo científico publicado en 2017

Pharmacokinetics and pharmacodynamics of sofosbuvir and ledipasvir for the treatment of hepatitis C.

artículo científico publicado en 2016

Positioning of lopinavir/ritonavir in antiretroviral treatment schemes

artículo científico publicado en 2014

Pre-transplant thymic function is associated with the risk of cytomegalovirus disease after solid organ transplantation.

artículo científico publicado en 2015

Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virus.

artículo científico publicado en 2010

Pretransplant interferon-γ secretion by CMV-specific CD8+ T cells informs the risk of CMV replication after transplantation.

artículo científico publicado en 2013

Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis coinfection: role of didanosine.

artículo científico publicado en 2010

Prevalence of hepatitis E virus infection in liver donors in Spain

article

Prevalence of hepatitis E virus infection in wild boars from Spain: a possible seasonal pattern?

artículo científico publicado en 2018

Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

artículo científico publicado en 2016

Prognostic Value of Transient Elastography in Human Immunodeficiency Virus-Infected Patients With Chronic Hepatitis C.

artículo científico publicado en 2016

Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis.

artículo científico publicado en 2015

Randomized trial of three regimens to prevent tuberculosis in HIV-infected patients with anergy

artículo científico publicado en 2003

Risk factors associated with hepatitis E virus in pigs from different production systems

artículo científico publicado en 2018

Risk of liver decompensation among HIV/hepatitis C virus-coinfected individuals with advanced fibrosis: implications for the timing of therapy.

artículo científico publicado en 2013

Risk of tuberculosis after lung transplantation: the value of pretransplant chest computed tomography and the impact of mTOR inhibitors and azathioprine use.

artículo científico publicado en 2016

Role of Hepatitis E Virus Infection in Acute-on-Chronic Liver Failure

scientific article published on 28 June 2018

Rural habitat as risk factor for hepatitis E virus seroconversion in HIV-infected patients: A prospective longitudinal study.

artículo científico publicado en 2017

Safety and efficacy of telaprevir in patients with HIV and hepatitis C virus coinfection

artículo científico publicado en 2013

Safety of atazanavir in patients with HIV and hepatitis B and/or C virus coinfection

artículo científico publicado en 2008

Safety, efficacy and indications of prescription of maraviroc in clinical practice: Factors associated with clinical outcomes

artículo científico publicado en 2015

Short Communication: Maraviroc Once-Daily: Experience in Routine Clinical Practice

artículo científico publicado en 2016

Short communication: atazanavir-based therapy is associated with higher hepatitis C viral load in HIV type 1-infected subjects with untreated hepatitis C

artículo científico publicado en 2012

Simplicity and efficacy of a once-daily antiretroviral regimen with didanosine, lamivudine, and efavirenz in naïve patients: the VESD study

scientific article published on 01 November 2005

Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferio

artículo científico publicado en 2016

Spontaneous clearance of chronic hepatitis C is rare in HIV-infected patients after effective use of combination antiretroviral therapy.

artículo científico publicado en 2017

Strategies for assignment of HIV-HCV genotype-1-coinfected patients to either dual-therapy or direct-acting antiviral agent-based triple-therapy

artículo científico publicado en 2013

Successful long-term treatment with linezolid for disseminated infection with multiresistant Nocardia farcinica.

artículo científico publicado en 2008

Sustained virological response in HIV/HCV co-infected patients treated with pegylated interferon/ribavirin can be predicted from the overall rate of viral load decline over the first 4 weeks of therapy.

artículo científico publicado en 2013

Sustained virological response to pegylated interferon plus ribavirin leads to normalization of liver stiffness in hepatitis C virus-infected patients.

artículo científico publicado en 2013

Sustained virological response with sofosbuvir and ledipasvir for hepatitis C virus genotype 5.

artículo científico publicado en 2016

The IL28B effect on hepatitis C virus kinetics among HIV patients after the first weeks of pegylated-interferon/ribavirin treatment varies according to hepatitis C virus-1 subtype.

artículo científico publicado en 2013

The efficacy and safety of maraviroc addition to a stable antiretroviral regimen in subjects with suppressed plasma HIV-RNA is not influenced by age.

artículo científico publicado en 2015

The impact of interleukin 28B rs12979860 single nucleotide polymorphism and liver fibrosis stage on response-guided therapy in HIV/HCV-coinfected patients.

artículo científico publicado en 2013

The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection.

artículo científico publicado en 2007

Tuberculosis in the transplant candidate: importance of early diagnosis and treatment.

artículo científico publicado en 2004

Twelve week post-treatment follow-up predicts sustained virological response to pegylated interferon and ribavirin therapy in HIV/hepatitis C virus co-infected patients.

artículo científico publicado en 2011

Use of high-dose ganciclovir for the treatment of cytomegalovirus replication in solid organ transplant patients with ganciclovir resistance-inducing mutations.

artículo científico

Use of maraviroc in patients with undetectable viral load: efficacy, tolerance and predictors of viral response in MARAVIROC-cohort study.

artículo científico publicado en 2014

Usefulness of Sputum Culture for Diagnosis of Bacterial Pneumonia in HIV-Infected Patients

article

Variations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infection.

artículo científico publicado en 2013

[Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection]

artículo científico publicado en 2000

[Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic stem cell transplant recipients].

artículo científico publicado en 2009

[Nocardiosis in patients with HIV infection]

scientific article published on 01 July 2002

Factores clínicos asociados a aspergilosis pulmonar invasiva en pacientes con neumopatías crónicas y aislamiento respiratorio de Aspergillus spp ⬇️

artículo científico publicado el 25 de octubre de 2012

¿Influye el coste de los medicamentos en la elección de las pautas del tratamiento antirretroviral? ⬇️

artículo científico publicado el 12 de noviembre de 2011

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda